Kevin D. Bunker - 10 Aug 2022 Form 4 Insider Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Signature
By: /s/ Melissa B. Epperly, Attorney-in-Fact for Kevin D. Bunker
Issuer symbol
ZNTL
Transactions as of
10 Aug 2022
Transactions value $
-$150,000
Form type
4
Filing time
12 Aug 2022, 16:26:47 UTC
Previous filing
20 Jul 2022
Next filing
03 Oct 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZNTL Common Stock Sale -$150K -5K -5% $30.00 95K 10 Aug 2022 See Footnote F1, F2
holding ZNTL Common Stock 764K 10 Aug 2022 Direct
holding ZNTL Common Stock 350 10 Aug 2022 As UTMA custodian for sons
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires October 31, 2022.
F2 Represents shares nominally held by Sundog Ranch, Inc. on behalf of the Bunker Family Protection Trust, the sole shareholder of Sundog Ranch, Inc. The Reporting Person and his wife are the primary beneficiaries of the Bunker Family Protection Trust and the Reporting Person and his wife are also directors of Sundog Ranch, Inc. The Reporting Person disclaims beneficial ownership of the securities held by Sundog Ranch, Inc. except to the extent of his pecuniary interest therein, if any.